Cartesian Therapeutics (NASDAQ: RNAC)

Cartesian Therapeutics

This clinical-stage biotechnology company develops mRNA cell therapies for patients with autoimmune diseases, including myasthenia gravis and myositis.

Orna Therapeutics

This company develops engineered circular RNA therapies and delivery systems to treat patients with cancer, autoimmune conditions, and genetic diseases.

Cabaletta Bio

This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.

Arcellx

This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.

Capstan Therapeutics

Capstan Therapeutics develops in vivo RNA-based therapies for patients with autoimmune diseases and cancers using targeted lipid nanoparticle technology.

Strand Therapeutics

This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.

ARTV

This clinical-stage biotechnology company develops natural killer cell therapies for patients with autoimmune diseases and cancers.

Typewriter Therapeutics

The company develops RNA-based genetic medicines for patients with cancer, autoimmune conditions and rare genetic diseases.